Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Swisher

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
Cancer Discovery|December 7, 2016
Culprit or Bystander? The Role of the Fallopian Tube in "Ovarian" High-Grade Serous CarcinomaElizabeth M Swisher, Rochelle L Garcia, Mark R Kilgore, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 20, 2025
Human epidermal growth factor receptor 2 targeted agents in gynecologic cancers: an updated reviewKendra Gee-Rodriguez, Amy Indorf, Elizabeth M Swisher, et al.
Frontiers in Digital Health|November 17, 2022
Barriers, interventions, and recommendations: Improving the genetic testing landscapeE J Dusic, Tesla Theoryn, Catharine Wang, et al.
Gynecologic Oncology|March 27, 2012
A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer riskTilley Jenkins Vogel, Kyrsten Stoops, Robin L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical TrialsSoledad Jorge, Shatreen Masshoor, Heidi J Gray, et al.
Journal of the National Cancer Institute|December 19, 2024
Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial accessAnn Oluloro, Elizabeth M Swisher, Heidi J Gray, et al.
Gynecologic Oncology Reports|June 19, 2023
Sertoli-Leydig cell tumor associated with a germline <i>DICER1</i> pathogenic variant diagnosed during pregnancy: Considerations for treatment, surveillance, and preventionJoyce Y Wang, Kimberly K Ma, Daniel J Reiter, et al.
Cancer Research|April 17, 2008
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistanceElizabeth M Swisher, Wataru Sakai, Beth Y Karlan, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 6, 2008
Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A reviewKimberly H Allison, Elizabeth Tenpenny, Susan D Reed, et al.
Gynecologic Oncology|March 17, 2023
What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black womenAnn Oluloro, Sarah M Temkin, Jonathan Jackson, et al.
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
Cancer Discovery|December 7, 2016
Culprit or Bystander? The Role of the Fallopian Tube in "Ovarian" High-Grade Serous CarcinomaElizabeth M Swisher, Rochelle L Garcia, Mark R Kilgore, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 20, 2025
Human epidermal growth factor receptor 2 targeted agents in gynecologic cancers: an updated reviewKendra Gee-Rodriguez, Amy Indorf, Elizabeth M Swisher, et al.
Frontiers in Digital Health|November 17, 2022
Barriers, interventions, and recommendations: Improving the genetic testing landscapeE J Dusic, Tesla Theoryn, Catharine Wang, et al.
Gynecologic Oncology|March 27, 2012
A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer riskTilley Jenkins Vogel, Kyrsten Stoops, Robin L Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical TrialsSoledad Jorge, Shatreen Masshoor, Heidi J Gray, et al.
Journal of the National Cancer Institute|December 19, 2024
Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial accessAnn Oluloro, Elizabeth M Swisher, Heidi J Gray, et al.
Gynecologic Oncology Reports|June 19, 2023
Sertoli-Leydig cell tumor associated with a germline <i>DICER1</i> pathogenic variant diagnosed during pregnancy: Considerations for treatment, surveillance, and preventionJoyce Y Wang, Kimberly K Ma, Daniel J Reiter, et al.
Cancer Research|April 17, 2008
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistanceElizabeth M Swisher, Wataru Sakai, Beth Y Karlan, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 6, 2008
Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A reviewKimberly H Allison, Elizabeth Tenpenny, Susan D Reed, et al.
Gynecologic Oncology|March 17, 2023
What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black womenAnn Oluloro, Sarah M Temkin, Jonathan Jackson, et al.
Pageof 20